COVID-19 treatment Bamlanivimab goes unused
COVID-19 vaccines have come fast but treatments for the disease are still limited. When a Canadian company developed Bamlanivimab, a new monoclonal antibody drug, Ottawa spent millions on doses. But after the rush to buy them they've sat on shelves for months, unused.
UP NEXT
UP NEXT
-
Lillian Bayne daughter of Dr. Ronald Bayne
cbc.ca
-
Dr. Ronald Bayne speaks about choosing a medically assisted death
cbc.ca
-
Capt. Sir Tom Moore, who raised millions for charity, honoured with WWII plane flypast at funeral
cbc.ca
-
Alleged stolen tow truck driver arrested
cbc.ca
-
Turning a lens on mental health
cbc.ca
-
D.O. Gibson spreads the knowledge of Black history through rap
cbc.ca
-
Saudi crown prince approved Khashoggi murder: U.S. intelligence report
cbc.ca
-
Indigenous communities devastated by boil-water advisory broken promises, says advocate
cbc.ca
-
Lockdown Showdown: Retired principal hits the ice
cbc.ca
-
Lockdown Showdown: Niverville man creates meat smoker out of office cabinet
cbc.ca
-
Lockdown Showdown: Fire and Ice
cbc.ca
-
How Indigenous communities are holding Round Dances virtually
cbc.ca
-
Lady Gaga offers $500,000 for safe return of stolen French bulldogs
cbc.ca
-
Senior advocate Dr. Ronald Bayne receives medically assisted death
cbc.ca
-
U.S. intelligence report blames Saudi crown prince for murder of Jamal Khashoggi
cbc.ca
-
Will Canadians be able to choose which COVID-19 vaccine they get?
cbc.ca